Is GLP-1 treatment $149 or $129 a month?

Longevixx says both, on the same page. The marquee across the top of its homepage reads "GLP-1 weight loss from $149/mo"; a band further down reads "Plans from $129/mo · confirmed after provider review". Neither program page — semaglutide, tirzepatide or microdose — carries any price at all, so there is no third source to settle it. Treat both as advertised floors and get the real figure confirmed before you commit.

Does Longevixx actually offer TRT or hormone therapy?

We could not find it. The scrolling marquee advertises "Hormone optimization · HRT & TRT", but there is no hormone page anywhere on the site — we tried both /hormones and /treatments and each returned a 404. Because of that, we have not listed Longevixx on our TRT board, applying the same rule we used for Enhance MD and EdgeRx: an announced or advertised product that is not live and verifiable on the provider's own site does not earn a board row. If you want hormone care, ask directly during the assessment rather than relying on the marquee.

Is the peptide catalog Longevixx's own?

No. All sixteen peptide products carry identical names and identical prices at Alinwell and Believe Health, with exactly one difference across the whole list — BPC-157 is $210 at Believe and $250 here and at Alinwell. The three are separate companies (Longevixx LLC, Alinwell LLC, Believe Health LLC), and they share a website build and a terms template in which the same sentences appear with only the company name changed. So comparing the three on peptide price or selection tells you almost nothing.

What does "$0 if you're not approved" cover?

It means you are not charged if a provider reviews your assessment and declines to treat you, which is a fair and increasingly common commitment in this category — Alinwell, Believe Health and The Edit all make it. It does not mean the assessment tells you the price before you complete it, and at Longevixx it does not: the figure is "confirmed after provider review". So the risk it removes is paying for a rejection, not the risk of being quoted more than the advertised floor.

Longevixx is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: Advertised from $149/mo in one band and $129/mo in another; program pages carry no price. 50 states. It is cash-pay and states it does not bill insurance. What our record does not establish: a single monthly price you can check before an intake. Ask for those in writing before you pay.

Updated September 2026

Longevixx review

Two entry prices, one page

Advertises GLP-1 from $149/mo in one band of its homepage and from $129/mo in another — and prices neither program page.

Our verdict

Longevixx is the longevity-framed member of a three-brand family, and it inherits both the strengths and the problems. The framing is coherent — GLP-1, peptides and hormone optimization presented as one healthspan program, with $0 charged if you are not approved and 50-state telehealth stated — and the peptide catalog is fully priced. But its own homepage carries two different GLP-1 entry prices, "from $149/mo" in the scrolling marquee and "Plans from $129/mo" in a band further down, and neither program page publishes a figure at all. Its marquee also advertises HRT and TRT, yet no hormone page exists on the site: both plausible URLs return 404. And the peptide catalog is not its own — it is identical to Alinwell's and Believe Health's, SKU for SKU.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →Advertised from $149/mo in one band and $129/mo in another; program pages carry no price. 50 states

At a glance

Category: GLP-1 telehealth
Access: Advertised from $149/mo in one band and $129/mo in another; program pages carry no price. 50 states
Medications: Compounded semaglutide · Compounded tirzepatide
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: 50 states
Updated: September 2026

What it is

A longevity-positioned telehealth service operated by Longevixx LLC, selling compounded semaglutide, tirzepatide and a GLP-1 microdose program alongside a peptide catalog organized into six clinical focus areas and an NAD+ injection line. It states telehealth in 50 states, provider-directed care and that nothing is charged if you are not approved.

How it works

Asynchronous, through a secure assessment described as confirming your fit, after which a provider decides whether treatment is appropriate. The site is explicit that plans are "confirmed after provider review", which is honest about the price being provisional but does not excuse the absence of a published figure on the program pages themselves. Products are described as compounded in a U.S. pharmacy; no pharmacy is named. The terms of service are the same boilerplate its two sibling brands use with the operating company swapped in.

Pricing transparency

The GLP-1 side is advertised twice and published nowhere. The marquee running across the top of the homepage reads "GLP-1 weight loss from $149/mo", while a band further down the same page reads "Plans from $129/mo · confirmed after provider review" — two different entry prices in one piece of furniture. Neither the semaglutide, tirzepatide nor microdose program page carries a price. The peptide catalog is fully priced and firm: MOTS-C $279/mo, tesamorelin $299, tesamorelin/ipamorelin $349, sermorelin $249, BPC-157 $250, BPC-157 acetate $199, BPC-157/TB500 $299, BPC-157/KPV/TB500 $329, BPC-157/GHK-Cu/KPV/TB500 $379, epithalon $249, GHK-Cu $249, GHK-Cu/epithalon $319, thymosin alpha-1 $299, DSIP $249, DSIP/BPC/CJC $329, semax/selank $299, NAD+ injection $199 and PT-141 $249. Every one of those figures matches Alinwell and Believe Health exactly, except BPC-157, which is $40 cheaper at Believe.

Branded vs compounded

Compounded semaglutide, tirzepatide and a GLP-1 microdose program, plus a compounded peptide catalog and NAD+ injection. Longevixx states that compounded medications are not FDA-approved six times across its pages. ⚠ Its marquee also advertises "Hormone optimization · HRT & TRT", but we could find no hormone or testosterone page anywhere on the site — both /hormones and /treatments return 404 — so we have not placed it on our TRT board and readers should not assume that line is a live product. On the evidence: GLP-1 outcome data belongs to the branded products; sermorelin, tesamorelin and CJC-1295/ipamorelin act on the growth-hormone axis with thin long-term outcome data; BPC-157, TB-500, KPV, DSIP and epithalon have little to no controlled human outcome evidence; injected NAD+ has none, with the randomized data on oral NR/NMN precursors; and PT-141 is approved only for HSDD in premenopausal women.

Pros and watch-outs

What we like

Peptide catalog fully priced and organized by clinical goal rather than molecule name
$0 charged if a provider does not approve you, stated prominently
50-state telehealth stated, with a coherent longevity framing across the whole menu
States that compounded medications are not FDA-approved, repeatedly

Watch-outs

Two different GLP-1 entry prices on the same homepage — $149/mo and $129/mo
No price on any GLP-1 program page
Advertises HRT and TRT with no hormone page on the site; both plausible URLs 404
Peptide catalog identical to Alinwell's and Believe Health's, SKU for SKU
No pharmacy named and no LegitScript seal displayed

Best for

Readers who want GLP-1 and peptides under one longevity framing and will confirm the actual price during the assessment.

Who should look elsewhere

Anyone comparing GLP-1 on published price, or counting on the advertised hormone and TRT line, which we could not find as a product.

The evidence behind what Longevixx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
BPC 157: what the evidence actually shows (and what it doesn't)
The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.
NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
PT-141 (bremelanotide): the evidence on a peptide that is actually FDA-approved
Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

How Longevixx compares

A few alternatives worth a look, depending on what you’re optimizing for.

Believe Health
Readers comparing the three storefronts that share this catalog on care model, not price
See Believe Health →
Alinwell
Women who want a GLP-1 program framed for them, with batch-level certificates published
See Alinwell →
NEUVÉ Health
Readers comparing injection against sublingual, and microdose against standard, on price
See NEUVÉ Health →

Compare all providers side by side →

More GLP-1 telehealth reviews: FORMCeliaRxEdgeRxthe edit.Trellis VitalityPepti

Nadia Feldman

Access & cost · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of Longevixx’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Is GLP-1 treatment $149 or $129 a month?: Longevixx says both, on the same page. The marquee across the top of its homepage reads "GLP-1 weight loss from $149/mo"; a band further down reads "Plans from $129/mo · confirmed after provider review". Neither program page — semaglutide, tirzepatide or microdose — carries any price at all, so there is no third source to settle it. Treat both as advertised floors and get the real figure confirmed before you commit.
Does Longevixx actually offer TRT or hormone therapy?: We could not find it. The scrolling marquee advertises "Hormone optimization · HRT & TRT", but there is no hormone page anywhere on the site — we tried both /hormones and /treatments and each returned a 404. Because of that, we have not listed Longevixx on our TRT board, applying the same rule we used for Enhance MD and EdgeRx: an announced or advertised product that is not live and verifiable on the provider's own site does not earn a board row. If you want hormone care, ask directly during the assessment rather than relying on the marquee.
Is the peptide catalog Longevixx's own?: No. All sixteen peptide products carry identical names and identical prices at Alinwell and Believe Health, with exactly one difference across the whole list — BPC-157 is $210 at Believe and $250 here and at Alinwell. The three are separate companies (Longevixx LLC, Alinwell LLC, Believe Health LLC), and they share a website build and a terms template in which the same sentences appear with only the company name changed. So comparing the three on peptide price or selection tells you almost nothing.
What does "$0 if you're not approved" cover?: It means you are not charged if a provider reviews your assessment and declines to treat you, which is a fair and increasingly common commitment in this category — Alinwell, Believe Health and The Edit all make it. It does not mean the assessment tells you the price before you complete it, and at Longevixx it does not: the figure is "confirmed after provider review". So the risk it removes is paying for a rejection, not the risk of being quoted more than the advertised floor.
Is Longevixx legit?: Longevixx is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: Advertised from $149/mo in one band and $129/mo in another; program pages carry no price. 50 states. It is cash-pay and states it does not bill insurance. What our record does not establish: a single monthly price you can check before an intake. Ask for those in writing before you pay.

Check availability →

Or compare every GLP-1 provider.